In prostate cancer, menin has been identified as an important co-factor for androgen receptor (AR) signaling by direct interaction with the N-terminal domain of the AR and recruitment of the MLL histone methyltransferase activity [9]. The gene discussed is KMT2A; the disease is prostate carcinoma.